Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Baglin

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.
British Journal of Haematology|May 8, 1999
Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutationK Brown, R Luddington, S A Taylor, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
Clinical and Laboratory Haematology|March 1, 1996
Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotoninP Mahendra, D M Keeling, I M Hood, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Prevention of infection by ciprofloxacin in neutropeniaR E Warren, J Z Wimperis, T P Baglin, et al.
Thrombosis Research|August 15, 1996
Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?S Rota, P D Flynn, N J Wareham, et al.
Clinical and Laboratory Haematology|January 1, 1992
Intra-ocular haemorrhage, a frequent complication of acute promyelocytic leukaemiaE M Richards, R E Marcus, P Harper, et al.
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein CA Brandts, A van Hylckama Vlieg, J Rosing, et al.
British Journal of Haematology|November 25, 2000
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)C R Hay, T P Baglin, P W Collins, et al.
Bone Marrow Transplantation|March 1, 1996
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity studyS Ager, P Mahendra, E M Richards, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|July 1, 1993
CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpuraS H Lim, G Hale, R E Marcus, et al.
British Journal of Haematology|May 8, 1999
Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutationK Brown, R Luddington, S A Taylor, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
Clinical and Laboratory Haematology|March 1, 1996
Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotoninP Mahendra, D M Keeling, I M Hood, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Prevention of infection by ciprofloxacin in neutropeniaR E Warren, J Z Wimperis, T P Baglin, et al.
Thrombosis Research|August 15, 1996
Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?S Rota, P D Flynn, N J Wareham, et al.
Clinical and Laboratory Haematology|January 1, 1992
Intra-ocular haemorrhage, a frequent complication of acute promyelocytic leukaemiaE M Richards, R E Marcus, P Harper, et al.
Journal of Thrombosis and Haemostasis : JTH|November 23, 2006
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein CA Brandts, A van Hylckama Vlieg, J Rosing, et al.
British Journal of Haematology|November 25, 2000
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)C R Hay, T P Baglin, P W Collins, et al.
Bone Marrow Transplantation|March 1, 1996
High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity studyS Ager, P Mahendra, E M Richards, et al.
Pageof 9